PD-1 antibody - Bamboo Works - China stock insights for global investors https://thebambooworks.com/tag/pd-1-antibody/ China stock insights for global investors Fri, 17 May 2024 06:27:19 +0000 en-GB hourly 1 https://wordpress.org/?v=6.1.1 https://thebambooworks.com/wp-content/uploads/2022/12/cropped-BBW_website_icon_20221228-32x32.png PD-1 antibody - Bamboo Works - China stock insights for global investors https://thebambooworks.com/tag/pd-1-antibody/ 32 32 FAST NEWS: Lepu Biopharma to raise $32 million in share sale https://thebambooworks.com/fast-news-lepu-biopharma-to-raise-32-million-in-share-sale/ Fri, 17 May 2024 05:34:10 +0000 https://thebambooworks.com/?p=32096 Lepu touts itself as the only biotech company in China working on all three very promising fronts, with PD-1 products in the new drug application (NDA) stage, multiple “smart missile” antibody-drug conjugate (ADC) products in clinical trials, and OV products under development.The Latest: Innovative drug maker Lepu Biopharma Co. Ltd. (2157.HK) announced on Friday it will place up to 51.17 million shares, or about 2.99% of its overall issued share capital, for a sale price of HK$4.58 per share. Looking Up: The company expects to receive approximately 230 million yuan ($32 million) in net proceeds from the.....

The post FAST NEWS: Lepu Biopharma to raise $32 million in share sale appeared first on Bamboo Works.

]]> Will Junshi Bio’s loss-making headaches ease with landmark U.S. drug approval? https://thebambooworks.com/will-junshi-bios-loss-making-headaches-ease-with-landmark-u-s-drug-approval/ Thu, 09 Nov 2023 05:23:20 +0000 https://thebambooworks.com/?p=24503 The FDA has given the nod to the Chinese company’s PD-1 drug, but most of the benefits will go to a third-party licensee Key Takeaways: 　 By Molly Wen In its ongoing quest to take its drugs overseas, China passed a major milestone late last month when Shanghai Junshi Biosciences Co. Ltd. (1877.HK; 688180.SH) announced.....

The post Will Junshi Bio’s loss-making headaches ease with landmark U.S. drug approval? appeared first on Bamboo Works.

]]> Lepu Biopharma gets taste of spring with first revenues https://thebambooworks.com/lepu-biopharma-gets-taste-of-spring-with-first-revenues/ Thu, 23 Mar 2023 03:38:53 +0000 https://thebambooworks.com/?p=17122 The ADC-focused drug company logged its first-ever sales late last year, kicking of the next phase of its development Key Takeaways: 　 By Molly Wen After years of cash burning to support its drug development and Hong Kong listing, Lepu Biopharma Co. Ltd. (2157.HK) has entered a new phase as it graduates from the ranks.....

The post Lepu Biopharma gets taste of spring with first revenues appeared first on Bamboo Works.

]]>